InMode Ltd.
INMDHealthcareNASDAQMedical Devices
Scan Results
Daily timeframePart of the healthcare sector, InMode Ltd. (INMD) is listed under Medical Devices. Valued at $820.9M, INMD is a small-cap name in its sector. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.
Market Cap
$820.9M
Beta
1.98
P/E (TTM)
10.00
P/E (Fwd)
9.28
EPS (TTM)
$1.35
EPS (Fwd)
$1.45
ROE
13.6%
ROA
6.9%
Cash
$537.2M
Total Debt
$4.8M
Free CF
$43.6M
52W Change
-8.3%
Annual Financials
Cash vs Debt
The balance sheet looks solid with $537.2M in cash comfortably exceeding the $4.8M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. The company generates $43.6M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 13.6% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 6.9% suggests reasonable efficiency in deploying the company's asset base. Revenue has pulled back from $454.3M (2022) to $370.5M (2025), a 18% decline worth watching.
InMode Ltd.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing INMD.